Desjardins Global Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	$84.8K	Buy	8,123 +1,070	+15%	+$11.2K	0.01%	487
2023 Q3	$71.9K	Buy	7,053 +234	+3%	+$2.39K	0.01%	504
2023 Q2	$51.3K	Hold	6,819	–	–	0.01%	536
2023 Q1	$60K	Buy	+6,819	New	+$60K	0.01%	510